Direxion Daily S&P Biotech Bull 3X ETF
LABU
LABU
41 hedge funds and large institutions have $84.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
13% less funds holding
Funds holding: 47 → 41 (-6)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
Holders
41
Holding in Top 10
–
Calls
$246M
Puts
$93.4M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$8.5M | |
| 3 | +$6.16M | |
| 4 |
Squarepoint
New York
|
+$3.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.27M |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$856K | |
| 3 | -$854K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$524K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$356K |